
Low-dose methotrexate in older adults with chronic kidney disease (CKD) is associated with a higher risk of serious adverse events compared to hydroxychloroquine.


coremsg

Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.

Methotrexate Carries Higher Risk for Older CKD Patients

higher-risk-of-serious-adverse-events-with-methotrexate-in-older-ckd-patients


Higher Risk of Serious Adverse Events with Methotrexate in Older CKD Patients
